Agenus Inc (AGEN): Cash & Equivalents
$3.00M
As of 2025-12-31
$18.74M
As of 2026-06-30
-74.4%
3-year compound annual growth
-50.4%
5-year compound annual growth
-31.7%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.00M | -92.6% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $40.44M | -46.9% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $76.11M | -57.4% | 2026-03-16, Balance as of period end |
| 2022-12-31 | $178.67M | -38.8% | 2025-03-17, Balance as of period end |
| 2021-12-31 | $291.93M | +192.3% | 2024-03-14, Balance as of period end |
| 2020-12-31 | $99.87M | +61.6% | 2023-03-16, Balance as of period end |
| 2019-12-31 | $61.81M | +16.5% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $53.05M | -11.9% | 2021-03-16, Balance as of period end |
| 2017-12-31 | $60.19M | -15.8% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $71.45M | -47.7% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $136.70M | +431.6% | 2018-03-16, Balance as of period end |
| 2014-12-31 | $25.71M | -6.0% | 2017-03-16, Balance as of period end |
| 2013-12-31 | $27.35M | +27.4% | 2016-03-15, Balance as of period end |
| 2012-12-31 | $21.47M | +99.7% | 2015-03-16, Balance as of period end |
| 2011-12-31 | $10.75M | -45.7% | 2014-03-07, Balance as of period end |
| 2010-12-31 | $19.78M | -1.4% | 2013-03-18, Balance as of period end |
| 2009-12-31 | $20.07M | n/a | 2012-03-06, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Agenus Inc (AGEN) | 2025-12-31 | $3.00M | -92.6% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | $88.33M | -38.4% |
| Century Therapeutics, Inc. (IPSC) | 2025-12-31 | $61.85M | +5.8% |
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | $8.48M | -66.1% |
| Monte Rosa Therapeutics, Inc. (GLUE) | 2025-12-31 | $129.88M | -42.1% |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $58.13M | -69.5% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $294.94M | +4.6% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $60.24M | -59.7% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $65.93M | -36.4% |
Compare AGEN, IBRX, IPSC, ATRA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗